Latest filing published 11 May 2026 for 贝瑞基因.
高扬: trading record in brief
高扬 (board member) discloses dealings in 贝瑞基因 to SSE / SZSE (CSRC). The record holds 5 filings, for trades running from 28 May 2025 to 11 May 2026.
No open-market purchase appears, only 4 sales worth €1.3M. So far in 2026, the count stands at no purchases and 2 sales.
The latest filing, published on 11 May 2026, reports an open-market sale of €132k in 贝瑞基因. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 高扬
Open company profiles for insider transactions, fundamentals and analyst consensus when available.